(NASDAQ: MDXH) Mdxhealth Sa's forecast annual revenue growth rate of 15.09% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.17%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.85%.
Mdxhealth Sa's revenue in 2025 is $94,507,000.On average, 1 Wall Street analysts forecast MDXH's revenue for 2025 to be $5,370,460,739, with the lowest MDXH revenue forecast at $5,370,460,739, and the highest MDXH revenue forecast at $5,370,460,739. On average, 1 Wall Street analysts forecast MDXH's revenue for 2026 to be $6,187,166,750, with the lowest MDXH revenue forecast at $6,187,166,750, and the highest MDXH revenue forecast at $6,187,166,750.
In 2027, MDXH is forecast to generate $7,031,096,295 in revenue, with the lowest revenue forecast at $7,031,096,295 and the highest revenue forecast at $7,031,096,295.